Condition
Severe Bacterial Infections
Total Trials
3
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 1 (1)
Trial Status
Not Yet Recruiting2
Unknown1
Clinical Trials (3)
Showing 3 of 3 trials
NCT07111793Not ApplicableNot Yet RecruitingPrimary
Identification of Clinical, Genetic and Immunological Factors Involved in the Development of Severe Bacterial Infections in Pediatrics
NCT07167524Not Yet Recruiting
Evaluation of the Dialytic Clearance of the Combination of Peracillin and Tazobactam
NCT04816968Phase 1UnknownPrimary
Antibiotics Continuous Infusion at Home
Showing all 3 trials